Susanne Miedlich, M.D.

I received my medical degree from Leipzig University in Germany. I then completed residency training in Internal Medicine both at Leipzig University Hospital and later at Wayne State University/Detroit Medical Center in Michigan, followed by a fellowship in Endocrinology, Diabetes, and Metabolism at...

I received my medical degree from Leipzig University in Germany. I then completed residency training in Internal Medicine both at Leipzig University Hospital and later at Wayne State University/Detroit Medical Center in Michigan, followed by a fellowship in Endocrinology, Diabetes, and Metabolism at the University of Rochester, after which I joined the division as faculty.

In line with my valuing knowledge and lifelong learning, my clinical interests have remained broad and include general endocrinology, including diabetes, thyroid, parathyroid, adrenal, and pituitary diseases, as well as gender-affirming hormone therapy for gender-diverse patients. That said, caring for patients with diabetes and/or obesity is where my true passion lies. I strive to address my patients' physical and mental health concerns (our division boasts a free counseling program as part of a collaboration with St. John Fisher College). I continue to learn with and from my patients. In addition to my clinical expertise, I have a solid background in basic science related to G-protein coupled receptors and steroid receptor signaling, and my research has been published in several peer-reviewed journals, such as JBC and Endocrinology.

I enjoy teaching students, residents, fellows, providers, and patients likewise. My current research, in collaboration with URMC internists, psychiatrists, and cardiologists, is focused on understanding and tackling obesity and diabetes in people with serious mental disorders. Despite the recent development and approval of powerful medical treatments in the fields of obesity and diabetes, these patients continue to be at a very high risk of adverse health outcomes, particularly from cardiometabolic diseases, which at least in part is owed to their limited access to comprehensive health care and screening, which we are working on changing.